Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
Journal of the American Heart Association|July 15, 2018
Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated CardiomyopathyBryon A Tompkins, Angela C Rieger, Victoria Florea, et al.
Infection Control and Hospital Epidemiology|February 5, 2008
Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005Preeta K Kutty, Stephen R Benoit, Christopher W Woods, et al.
Oncogene|June 14, 2011
Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancerG S Coombs, A A Schmitt, C A Canning, et al.
Transfusion|January 5, 2002
Transfusion-transmitted bacterial infection in the United States, 1998 through 2000M J Kuehnert, V R Roth, N R Haley, et al.
Cardiovascular Research|February 14, 2020
The impact of patient sex on the response to intramyocardial mesenchymal stem cell administration in patients with non-ischaemic dilated cardiomyopathyVictoria Florea, Angela C Rieger, Makoto Natsumeda, et al.
Infection Control and Hospital Epidemiology|March 31, 2010
Catheter-related polymicrobial bloodstream infections among pediatric bone marrow transplant outpatients--Atlanta, Georgia, 2007Petra Wiersma, Sarah Schillie, Harry Keyserling, et al.
Infection Control and Hospital Epidemiology|July 26, 2002
Prevalence of surgical-site infections and patterns of antimicrobial use in a large tertiary-care hospital in Ho Chi Minh City, VietnamAnnette H Sohn, Farah M Parvez, Tien Vu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2017
Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trialsAngela George, Rebecca Kristeleit, Saeed Rafii, et al.
Physical Review Letters|August 16, 2020
CBETA: First Multipass Superconducting Linear Accelerator with Energy RecoveryA Bartnik, N Banerjee, D Burke, et al.
Gynecologic Oncology|August 20, 2021
A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trialSusana N Banerjee, Monica Tang, Rachel L O'Connell, et al.
Pageof 29